Developer docs
API playgroundTry for free, no card

Search company profiles

Remebot

Full company profile

uuid0002m7z

Namestring
Remebot
Legal namestring
柏惠维康(重庆)机器人股份有限公司
Websiteurl
remebot.com.cn
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops, manufactures, and sells minimally invasive surgical robot systems across three medical verticals: neurosurgery, orthopedics, and oral surgery. The company's core technology combines multi-modal image fusion (CT, MRI, PET, DTI), proprietary optical tracking and positioning (Reme-Intelligence™), and a six-axis robotic arm to deliver sub-millimeter precision (≤0.5mm for oral surgery, ≤1mm for neurosurgery) for complex procedures. Its flagship product is the Remebot (睿米) neurosurgical robot, which received China's first CFDA/NMPA Class III medical device registration for a neurosurgical robot in April 2018 and supports 12 categories of nearly 100 neurosurgical procedures including DBS, SEEG, biopsy, and hematoma aspiration. The company subsequently launched the Ruiyibo (瑞医博) oral surgery robot (China's first NMPA-approved oral surgical robot, April 2021), the orthopedic surgery robot with spine module, and the RM-50 brain hemorrhage robot variant, bringing its total to 8 NMPA product registrations.

Remebot generates revenue primarily through direct hardware sales of surgical robot systems to tertiary hospitals and dental clinics, supplemented by associated surgical planning software and modules. The company employs an enterprise field sales model targeting top-tier hospitals, with marketing supported by participation in major medical conferences (CNS, CAAE, China Med, CMEF, World Robot Conference), the Remebot Academy (睿米学院) surgeon training program, and PR through CCTV and other national media. By 2023 the company reported its products deployed across all 31 provinces of China, with expansion into Central Asian and Southeast Asian markets, and clinical collaborations with leading hospitals including Beijing Tiantan Hospital, Xuanwu Hospital, 301 Hospital, and nearly 30 top-tier hospitals, with over 20,000 clinical cases accumulated. Strategic partnerships include the National Neurosurgery Robot Application Demonstration Project with 9 leading hospitals and a distribution channel partnership with Shanghai Electric Medical Group. The company is headquartered in Chongqing (registered entity) with R&D operations in Beijing, holds 100+ IP rights including 70+ invention patents, and has raised approximately 560M RMB (~$85M) in cumulative disclosed funding including a 430M RMB Series D in December 2020 led by Zhongguancun Longmen Fund.

Short descriptiontext

Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops and sells NMPA-approved neurosurgery, orthopedic, and oral surgery robot systems with sub-millimeter precision, serving tertiary hospitals and dental clinics across all 31 provinces of China.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical robotics, neurosurgical navigation, dental implant robot, medical image fusion, robotic-assisted surgery
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Surgical Robotics
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Neurosurgical Surgical Robot Sales
TypeHardware Sales
Description

Sale of Remebot neurosurgical surgical robot systems to hospitals, including hardware, software, and installation

remebot.com.cn
2Oral Surgery Robot Sales
TypeHardware Sales
Description

Sale of Ruivbo (瑞医博) dental implant surgical robots to dental clinics and hospitals

remebot.com.cn
3Orthopedic Surgical Robot
TypeHardware Sales
Description

Sale of orthopedic surgical robot products across three major medical fields: neurosurgery, orthopedics, and oral surgery

remebot.com.cn
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1睿米 (Remebot)
Description

Neurosurgical surgical robot brand. The flagship neurosurgical navigation and positioning system assists doctors in completing twelve categories of neurosurgical procedures with precision, minimal invasiveness, and high efficiency. Covers DBS, SEEG, aspiration/drainage, intracranial biopsy, percutaneous puncture, visual navigation, and endoscope navigation applications.

remebot.com.cn
+6 more records
Core offering1 text field

Remebot designs, manufactures, and sells surgical robot systems for neurosurgery, orthopedic, and oral/dental surgery. The flagship Remebot neurosurgery robot provides sub-millimeter positioning accuracy using multi-modal image fusion and optical tracking, supporting 12 categories of nearly 100 neurosurgical procedures. The Ruiyibo oral surgery robot handles dental implant procedures with ≤0.5mm distance deviation and ≤1° angle deviation. The orthopedic robot extends the platform to spine and bone procedures. Products are sold to hospitals and clinics with hardware, software, installation, and training bundled.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Positioning accuracy ≤0.5mm for oral surgery and ≤1mm for neurosurgery
+4 more records
Product overview1 text field

Remebot (柏惠维康) is a surgical robotics company offering a portfolio of three core surgical robot brands spanning neurosurgery, orthopedics, and oral surgery. The flagship 睿米® neurosurgery robot received China's first CFDA Class III certification for neurosurgical robots in 2018, while 瑞医博® oral surgery robot became China's first domestically-developed oral surgery robot to receive NMPA approval in 2021. The company also offers 睿米® orthopedic robot. All three core brands share the company's proprietary Reme-Intelligence™ optical tracking system and surgical planning software platform. The neurosurgery system supports multiple add-on modules including endoscopy, navigation, and spine modules. The systems provide multi-modal image fusion (CT, MRI, PET, DTI), real-time optical tracking, and automated positioning for precise surgical navigation.

Product and service4 records
1Remebot Neurosurgery Robot (睿米®神经外科手术机器人)
CategoryNeurosurgical Robotic Systems
Description

Neurosurgery surgical navigation and positioning robot that assists doctors in performing minimally invasive, precise, and efficient neurosurgical procedures across 12 categories of nearly 100 types of surgeries including DBS (deep brain stimulation), SEEG (stereoelectroencephalography) electrode implantation, biopsy, hematoma aspiration, intracranial biopsy, percutaneous puncture, visual navigation, and endoscope navigation. Used by top-tier hospital neurosurgery departments.

2Ruiyibo Oral Surgery Robot (瑞医博®口腔手术机器人)
CategoryDental Surgical Robotic Systems
Description

Dental implant surgery robot that assists doctors in performing precise dental implant procedures with distance deviation ≤0.5mm and angle deviation ≤1°. Covers all tooth positions including immediate implantation in aesthetic zones, bone augmentation-assisted implantation, single jaw continuous multi-implant, full-arch edentulous implantation, zygomatic implantation, and embedded tooth window surgery. Used by hospital dental departments and dental implant clinics.

3Remebot Orthopedic Surgery Robot (睿米®骨科手术机器人)
CategoryOrthopedic Surgical Robotic Systems
Description

Orthopedic surgery robot for spinal and bone procedures. The spine module extends the neurosurgery robot's active safety technology to track six-dimensional spinal segment drift in real-time, guiding the robotic arm to actively correct positioning for precise spinal localization. Used by hospital orthopedic departments.

4Remebot RM-50 Brain Hemorrhage Surgical Robot (睿米®RM-50)
CategoryNeurosurgical Robotic Systems - Brain Hemorrhage
Description

Brain hemorrhage surgical robot variant, China's first NMPA-certified brain hemorrhage surgery robot product. Composed of independently-developed computer software (brain), optical tracking positioning system (eye), and domestic six-axis robotic arm (hand). Used for cerebral hemorrhage procedures.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1National Neurosurgery Robot Application Demonstration Project (国家神经外科手术机器人应用示范项目)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2019-09-01
Description

Led by Ministry of Industry and Information Technology and National Health Commission; 9 leading hospitals as initiative members; completed over 1,000 robotic surgeries

remebot.com.cn
2Beijing Tiantan Hospital (北京天坛医院)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Lead hospital for clinical trials; pioneered first domestic robot-assisted DBS surgery; completed over 100 robotic surgeries

remebot.com.cn
3Xuanwu Hospital (宣武医院)
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Clinical trial partner; collaborated on National Research Center for Medical Image Navigation Positioning Surgery Robot

remebot.com.cn
4301 Hospital (解放军总医院)
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Led 5G remote surgery development; pioneer in remote robotic DBS procedures

remebot.com.cn
5Shanghai Electric Medical Group (上海电气康达医疗)
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Strategic partnership for market expansion; exhibited at CMEF together; leverages Shanghai Electric's distribution network

remebot.com.cn
6China Association for Medical Equipment (中国医学装备协会)
Strategic tierMinorTypeOthers
Description

Member unit of China Association for Medical Equipment

remebot.com.cn
7China Medical Equipment AI Alliance (中国医疗装备人工智能联盟)
Strategic tierMinorTypeOthers
Description

Council member unit of China Medical Equipment AI Alliance

remebot.com.cn
8Zhongguancun Frontier Technology and Industry Service Alliance (中关村前沿科技与产业服务联盟)
Strategic tierMinorTypeOthers
Description

Council member unit

remebot.com.cn
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Operates the Rosa robotics platform for neurosurgery, spine, and knee. Comparable as a multi-indication incumbent whose neurosurgery and spine applications overlap with Remebot's Remebot neurosurgery robot and orthopedic spine module.

TypeDirect peer
Description

China's leading orthopedic/spine surgical robotics company and the first A-share listed domestic surgical robot maker. Directly comparable to Remebot's orthopedic franchise and competing in similar Chinese tertiary hospital channels.

TypeDirect peer
Description

Chinese single-port laparoscopic surgical robot developer competing for hospital capital budgets across multiple surgical specialties. Comparable as a domestic surgical robotics challenger targeting similar tier-1 Chinese hospital customers.

TypeDirect peer
Description

China-based multi-port and single-port laparoscopic surgical robot company with NMPA approvals and growing hospital deployments. Comparable as a capital-rich Chinese surgical robotics peer competing for similar hospital procurement cycles.

TypeDirect peer
Description

US-based dental implant surgical robot (Yomi), the first FDA-cleared dental implant robot. Direct comparable to Remebot's Ruiyibo oral surgery robot franchise in product category, regulatory pathway, and dental implant use case.

TypeDirect peer
Description

Germany-based surgical navigation and robotics platform with significant neurosurgical and spine footprint. Closely comparable to Remebot's neurosurgical navigation and positioning technology in optical tracking, image fusion, and cranial/spinal use cases.

TypeDirect peer
Description

UK-based manufacturer of the Neuromate stereotactic neurosurgical robot used for DBS, SEEG, and biopsy. Direct comparable in neurosurgical robotics technology and indications, though serving primarily European clinical sites.

TypeBroad incumbent
Description

Global leader in surgical robotics via the Da Vinci platform. While Remebot does not directly compete in laparoscopic soft-tissue robotics, Intuitive sets the benchmark for hospital capital sales, surgeon training, and recurring revenue economics that Remebot aspires to emulate.

TypeBroad incumbent
Description

Operates the Mazor robotic spine surgery platform and StealthStation surgical navigation — both direct competitors in the spinal and neurosurgical navigation indications where Remebot's spine module and Remebot neurosurgery robot compete.

TypeBroad incumbent
Description

Global orthopedic surgical robotics leader with the Mako platform. Comparable as a broad incumbent in orthopedic surgical robotics and a benchmark for hospital salesforce scale, clinical evidence generation, and capital equipment pricing strategy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Remebot

Surgical Roboticsremebot.com.cn

Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops and sells NMPA-approved neurosurgery, orthopedic, and oral surgery robot systems with sub-millimeter precision, serving tertiary hospitals and dental clinics across all 31 provinces of China.

What Remebot does

Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops, manufactures, and sells minimally invasive surgical robot systems across three medical verticals: neurosurgery, orthopedics, and oral surgery. The company's core technology combines multi-modal image fusion (CT, MRI, PET, DTI), proprietary optical tracking and positioning (Reme-Intelligence™), and a six-axis robotic arm to deliver sub-millimeter precision (≤0.5mm for oral surgery, ≤1mm for neurosurgery) for complex procedures. Its flagship product is the Remebot (睿米) neurosurgical robot, which received China's first CFDA/NMPA Class III medical device registration for a neurosurgical robot in April 2018 and supports 12 categories of nearly 100 neurosurgical procedures including DBS, SEEG, biopsy, and hematoma aspiration. The company subsequently launched the Ruiyibo (瑞医博) oral surgery robot (China's first NMPA-approved oral surgical robot, April 2021), the orthopedic surgery robot with spine module, and the RM-50 brain hemorrhage robot variant, bringing its total to 8 NMPA product registrations.

Remebot generates revenue primarily through direct hardware sales of surgical robot systems to tertiary hospitals and dental clinics, supplemented by associated surgical planning software and modules. The company employs an enterprise field sales model targeting top-tier hospitals, with marketing supported by participation in major medical conferences (CNS, CAAE, China Med, CMEF, World Robot Conference), the Remebot Academy (睿米学院) surgeon training program, and PR through CCTV and other national media. By 2023 the company reported its products deployed across all 31 provinces of China, with expansion into Central Asian and Southeast Asian markets, and clinical collaborations with leading hospitals including Beijing Tiantan Hospital, Xuanwu Hospital, 301 Hospital, and nearly 30 top-tier hospitals, with over 20,000 clinical cases accumulated. Strategic partnerships include the National Neurosurgery Robot Application Demonstration Project with 9 leading hospitals and a distribution channel partnership with Shanghai Electric Medical Group. The company is headquartered in Chongqing (registered entity) with R&D operations in Beijing, holds 100+ IP rights including 70+ invention patents, and has raised approximately 560M RMB (~$85M) in cumulative disclosed funding including a 430M RMB Series D in December 2020 led by Zhongguancun Longmen Fund.

Remebot firmographics

Firmographics
Name
Remebot
Legal name
柏惠维康(重庆)机器人股份有限公司
Website
https://remebot.com.cn
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops and sells NMPA-approved neurosurgery, orthopedic, and oral surgery robot systems with sub-millimeter precision, serving tertiary hospitals and dental clinics across all 31 provinces of China.
Ownership category
akta.pro rank

Remebot industry classification

Industry
Product category
Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)

Keywords

  • Surgical robotics
  • Neurosurgical navigation
  • Dental implant robot
  • Medical image fusion
  • Robotic-assisted surgery

Where Remebot is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices2 records

Markets served

Remebot business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Neurosurgical Surgical Robot Sales: Sale of Remebot neurosurgical surgical robot systems to hospitals, including hardware, software, and installation
  2. Oral Surgery Robot Sales: Sale of Ruivbo (瑞医博) dental implant surgical robots to dental clinics and hospitals
  3. Orthopedic Surgical Robot: Sale of orthopedic surgical robot products across three major medical fields: neurosurgery, orthopedics, and oral surgery

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Remebot product offering

Product offering

Core offering

Remebot designs, manufactures, and sells surgical robot systems for neurosurgery, orthopedic, and oral/dental surgery. The flagship Remebot neurosurgery robot provides sub-millimeter positioning accuracy using multi-modal image fusion and optical tracking, supporting 12 categories of nearly 100 neurosurgical procedures. The Ruiyibo oral surgery robot handles dental implant procedures with ≤0.5mm distance deviation and ≤1° angle deviation. The orthopedic robot extends the platform to spine and bone procedures. Products are sold to hospitals and clinics with hardware, software, installation, and training bundled.

Product overview

Remebot (柏惠维康) is a surgical robotics company offering a portfolio of three core surgical robot brands spanning neurosurgery, orthopedics, and oral surgery. The flagship 睿米® neurosurgery robot received China's first CFDA Class III certification for neurosurgical robots in 2018, while 瑞医博® oral surgery robot became China's first domestically-developed oral surgery robot to receive NMPA approval in 2021. The company also offers 睿米® orthopedic robot. All three core brands share the company's proprietary Reme-Intelligence™ optical tracking system and surgical planning software platform. The neurosurgery system supports multiple add-on modules including endoscopy, navigation, and spine modules. The systems provide multi-modal image fusion (CT, MRI, PET, DTI), real-time optical tracking, and automated positioning for precise surgical navigation.

Differentiator

Problem solved

Functional benefit

Brands

  • 睿米 (Remebot): Neurosurgical surgical robot brand. The flagship neurosurgical navigation and positioning system assists doctors in completing twelve categories of neurosurgical procedures with precision, minimal invasiveness, and high efficiency. Covers DBS, SEEG, aspiration/drainage, intracranial biopsy, percutaneous puncture, visual navigation, and endoscope navigation applications.
  • 瑞医博 (Ruiyibo)
  • 睿米 RM-50
  • 睿见精彩 (Ruijian Jingcai)
  • 睿米学院
  • Reme-Intelligence
  • 瑞医博 (Ruiyibo Dental Robot)

Products and services

  • Remebot Neurosurgery Robot (睿米®神经外科手术机器人) Neurosurgery surgical navigation and positioning robot that assists doctors in performing minimally invasive, precise, and efficient neurosurgical procedures across 12 categories of nearly 100 types of surgeries including DBS (deep brain stimulation), SEEG (stereoelectroencephalography) electrode implantation, biopsy, hematoma aspiration, intracranial biopsy, percutaneous puncture, visual navigation, and endoscope navigation. Used by top-tier hospital neurosurgery departments.
  • Ruiyibo Oral Surgery Robot (瑞医博®口腔手术机器人) Dental implant surgery robot that assists doctors in performing precise dental implant procedures with distance deviation ≤0.5mm and angle deviation ≤1°. Covers all tooth positions including immediate implantation in aesthetic zones, bone augmentation-assisted implantation, single jaw continuous multi-implant, full-arch edentulous implantation, zygomatic implantation, and embedded tooth window surgery. Used by hospital dental departments and dental implant clinics.
  • Remebot Orthopedic Surgery Robot (睿米®骨科手术机器人) Orthopedic surgery robot for spinal and bone procedures. The spine module extends the neurosurgery robot's active safety technology to track six-dimensional spinal segment drift in real-time, guiding the robotic arm to actively correct positioning for precise spinal localization. Used by hospital orthopedic departments.
  • Remebot RM-50 Brain Hemorrhage Surgical Robot (睿米®RM-50) Brain hemorrhage surgical robot variant, China's first NMPA-certified brain hemorrhage surgery robot product. Composed of independently-developed computer software (brain), optical tracking positioning system (eye), and domestic six-axis robotic arm (hand). Used for cerebral hemorrhage procedures.

Quantifiable outcome

  • Positioning accuracy ≤0.5mm for oral surgery and ≤1mm for neurosurgery
  • +4 more outcomes

Companies that use Remebot

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Remebot technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Remebot partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, major and minor.

  • National Neurosurgery Robot Application Demonstration Project (国家神经外科手术机器人应用示范项目)flagshipStrategic or Co-development Partner · 1 September 2019Led by Ministry of Industry and Information Technology and National Health Commission; 9 leading hospitals as initiative members; completed over 1,000 robotic surgeries
  • Beijing Tiantan Hospital (北京天坛医院)flagshipStrategic or Co-development Partner · 1 January 2019Lead hospital for clinical trials; pioneered first domestic robot-assisted DBS surgery; completed over 100 robotic surgeries
  • Xuanwu Hospital (宣武医院)flagshipStrategic or Co-development PartnerClinical trial partner; collaborated on National Research Center for Medical Image Navigation Positioning Surgery Robot
  • 301 Hospital (解放军总医院)flagshipStrategic or Co-development PartnerLed 5G remote surgery development; pioneer in remote robotic DBS procedures
  • Shanghai Electric Medical Group (上海电气康达医疗)majorChannel Partner/ Reseller/ DistributorStrategic partnership for market expansion; exhibited at CMEF together; leverages Shanghai Electric's distribution network
  • China Association for Medical Equipment (中国医学装备协会)minorOthersMember unit of China Association for Medical Equipment
  • China Medical Equipment AI Alliance (中国医疗装备人工智能联盟)minorOthersCouncil member unit of China Medical Equipment AI Alliance
  • Zhongguancun Frontier Technology and Industry Service Alliance (中关村前沿科技与产业服务联盟)minorOthersCouncil member unit

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Remebot competitors and assessment

Company assessment

Broad incumbents

  • Zimmer Biomet (Rosa): Operates the Rosa robotics platform for neurosurgery, spine, and knee. Comparable as a multi-indication incumbent whose neurosurgery and spine applications overlap with Remebot's Remebot neurosurgery robot and orthopedic spine module.
  • Intuitive Surgical: Global leader in surgical robotics via the Da Vinci platform. While Remebot does not directly compete in laparoscopic soft-tissue robotics, Intuitive sets the benchmark for hospital capital sales, surgeon training, and recurring revenue economics that Remebot aspires to emulate.
  • Medtronic (Mazor / StealthStation): Operates the Mazor robotic spine surgery platform and StealthStation surgical navigation — both direct competitors in the spinal and neurosurgical navigation indications where Remebot's spine module and Remebot neurosurgery robot compete.
  • Stryker (Mako): Global orthopedic surgical robotics leader with the Mako platform. Comparable as a broad incumbent in orthopedic surgical robotics and a benchmark for hospital salesforce scale, clinical evidence generation, and capital equipment pricing strategy.

Direct peers

  • TINAVI (天智航天智航): China's leading orthopedic/spine surgical robotics company and the first A-share listed domestic surgical robot maker. Directly comparable to Remebot's orthopedic franchise and competing in similar Chinese tertiary hospital channels.
  • Shurui Robot (术锐机器人): Chinese single-port laparoscopic surgical robot developer competing for hospital capital budgets across multiple surgical specialties. Comparable as a domestic surgical robotics challenger targeting similar tier-1 Chinese hospital customers.
  • Edge Medical (精锋医疗): China-based multi-port and single-port laparoscopic surgical robot company with NMPA approvals and growing hospital deployments. Comparable as a capital-rich Chinese surgical robotics peer competing for similar hospital procurement cycles.
  • Neocis (Yomi): US-based dental implant surgical robot (Yomi), the first FDA-cleared dental implant robot. Direct comparable to Remebot's Ruiyibo oral surgery robot franchise in product category, regulatory pathway, and dental implant use case.
  • Brainlab: Germany-based surgical navigation and robotics platform with significant neurosurgical and spine footprint. Closely comparable to Remebot's neurosurgical navigation and positioning technology in optical tracking, image fusion, and cranial/spinal use cases.
  • Renishaw (Neuromate): UK-based manufacturer of the Neuromate stereotactic neurosurgical robot used for DBS, SEEG, and biopsy. Direct comparable in neurosurgical robotics technology and indications, though serving primarily European clinical sites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Remebot compliance and trust

Trust signal

Compliance1 record

Remebot financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Remebot leadership team

Management profile

Number of profiles

Profiles5 records

Remebot subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Remebot funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Remebot M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remebot

What does Remebot do?

Remebot designs, manufactures, and sells surgical robot systems for neurosurgery, orthopedic, and oral/dental surgery. The flagship Remebot neurosurgery robot provides sub-millimeter positioning accuracy using multi-modal image fusion and optical tracking, supporting 12 categories of nearly 100 neurosurgical procedures. The Ruiyibo oral surgery robot handles dental implant procedures with ≤0.5mm distance deviation and ≤1° angle deviation. The orthopedic robot extends the platform to spine and bone procedures. Products are sold to hospitals and clinics with hardware, software, installation, and training bundled.

Is Remebot a public or private company?

Remebot is a private company. It is classified as venture growth investor backed and is currently operating.

When was Remebot founded?

Remebot was founded in 2010. It employs 11 to 50 people.

Where is Remebot based?

Remebot is headquartered in Beijing, China, in the Asia region.

How does Remebot make money?

Three revenue lines are on record. Neurosurgical Surgical Robot Sales are the primary driver. The others are oral Surgery Robot Sales and orthopedic Surgical Robot.

Who are Remebot's main competitors?

Broad incumbents on record are Zimmer Biomet (Rosa), Intuitive Surgical, Medtronic (Mazor / StealthStation) and Stryker (Mako). Direct peers are TINAVI (天智航天智航), Shurui Robot (术锐机器人), Edge Medical (精锋医疗), Neocis (Yomi), Brainlab and Renishaw (Neuromate).

Does Remebot have an API?

No public API is recorded for Remebot.

What industry is Remebot in?

Remebot's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireChina Medical Robotics Industry Report, 2016-2020China has been dependent on Da Vinci surgical systems imported from US-based Intuitive Surgical, with over 50 surgical robots installed in more than 40 Chinese hospitals as of end-2015, performing 22,917 cumulative surgeries. Domestic companies including Beijing TINAVI, Remebot, and Tianjin University are advancing Chinese medical robotics with support from national policies and subsidies, with several products at various stages of CFDA registration or clinical application. The report notes that many Chinese enterprises entering rehabilitation and dispensing robot fields generally lack core technologies and will require substantial R&D investment to remain competitive.PR NewswireChina Medical Robotics Industry Report, 2016-2020China's medical robotics industry remains largely dependent on Intuitive Surgical's Da Vinci system, with over 40 hospitals having installed more than 50 surgical robots by the end of 2015. Chinese companies are now advancing their own surgical and rehabilitation robotics capabilities with support from national policies, with several products including Beijing TINAVI's orthopedic surgery robot and Remebot expecting regulatory approval or commercialization around late 2016 to 2017. The rehabilitation and dispensing robot segments are attracting multiple Chinese enterprises, though these companies generally lack core technologies and face significant R&D investment requirements.